Keynote B21 - Pembrolizumab in High-Risk Endometrial Cancer (Video Explainer) Last updated on Oct 27, 2024 Previous KEYNOTE-B21: Pembrolizumab Plus Adjuvant Chemotherapy in High-Risk Endometrial Cancer Next The Living Room
